These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2815744
1. [Study of the effects of calcium antagonists on respiration mechanics in patients with occlusive ventilation impairment]. Frank-Piskorska A, Wasek Z, Malinowski R. Wiad Lek; 1989 Mar 01; 42(5):278-83. PubMed ID: 2815744 [Abstract] [Full Text] [Related]
3. [Evaluation of the protective effects of nifedipine and verapamil in patients with bronchial hyperreactivity]. Malinowski R, Wasek Z, Frank-Piskorska A. Wiad Lek; 1989 Feb 01; 42(3):129-33. PubMed ID: 2696203 [Abstract] [Full Text] [Related]
4. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy]. Korovina EP. Klin Med (Mosk); 1998 Feb 01; 76(12):30-5. PubMed ID: 10067289 [Abstract] [Full Text] [Related]
6. [Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction]. Sakai M, Ueda K, Nakahara K, Tsuchimochi H, Mutsushita S, Kuramoto K, Murakami M. Kokyu To Junkan; 1985 Feb 01; 33(2):159-64. PubMed ID: 4001593 [No Abstract] [Full Text] [Related]
7. Effect of calcium channel antagonists on cholinergic bronchial responsiveness in asthma. Talwar D, Jindal SK. J Assoc Physicians India; 1993 May 01; 41(5):279-80. PubMed ID: 8300460 [Abstract] [Full Text] [Related]
8. [Comparison of the anti-angina effect of the calcium antagonists diltiazem, nifedipine and verapamil with each other and with propranolol]. Ferrero JA, Asensi JF, Madrigal JA, Haba J, Chorro FJ, López Merino V. Rev Esp Cardiol; 1987 May 01; 40(4):249-55. PubMed ID: 3659517 [No Abstract] [Full Text] [Related]
9. [Use of calcium antagonists in therapy of bronchial asthma]. Alekseev VG, Sinopal'nikov AI, Efimov AV. Ter Arkh; 1989 May 01; 61(3):27-31. PubMed ID: 2741111 [Abstract] [Full Text] [Related]
10. Non-invasive electrophysiological evaluation of calcium antagonist long-term therapy. Adinolfi L, Golia B, Montano A, Marino M, Napolano S, Mazza F. Int J Clin Pharmacol Ther Toxicol; 1987 Dec 01; 25(12):670-2. PubMed ID: 3436687 [Abstract] [Full Text] [Related]
11. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review. Opie LH. Q J Med; 1984 Dec 01; 53(209):1-16. PubMed ID: 6324268 [Abstract] [Full Text] [Related]
13. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?]. Blagova OV, Nedostup AV. Ter Arkh; 2006 Dec 01; 78(8):30-8. PubMed ID: 17078214 [Abstract] [Full Text] [Related]
18. Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem. Schwartz DJ, Wasserstrom JA, Fozzard HA. Compr Ther; 1981 Oct 01; 7(10):25-33. PubMed ID: 7297044 [No Abstract] [Full Text] [Related]
19. Calcium-channel antagonists in cardiovascular disease. Holdright DR. Br J Hosp Med; 1981 Oct 01; 57(11):552-6. PubMed ID: 9307671 [Abstract] [Full Text] [Related]
20. [Usefulness and limitations of the ergonovine maleate test in the evaluation of calcium-antagonist therapy in Prinzmetal variant angina]. Previtali M, Salerno JA, Panciroli C, Moizi M, Chimienti M, Montemartini C, Bobba P. G Ital Cardiol; 1986 Oct 01; 16(10):863-71. PubMed ID: 3817369 [Abstract] [Full Text] [Related] Page: [Next] [New Search]